Browse every story filed under this topic, curated from trusted publishers around the world.
The strategic investments expanding CDMO capabilities for HPAPIs and ADCs
Demand for HPAPIs and ADCs is accelerating, prompting CDMOs to invest to strengthen manufacturing capabilities for oncology. The post The strategic investments expanding CDMO capabilities for HPAPIs and ADCs appeared first on Clinical Trials Arena.
Read full story →
Kyowa Kirin and Kura initiate Phase II trial of ziftomenib for AML
Kyowa Kirin and Kura Oncology have begun a Japanese Phase II registrational study of ziftomenib in adult patients with r/r …
Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
Daiichi Sankyo has postponed its annual report by two weeks, citing additional time needed to review “the supply plans for …
Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care
As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in …
Pancreatic cancer pill, vaccine show promise: What to know
Two potential pancreatic cancer treatments are gaining recognition within the oncology community, according to reports from The New York Times …
STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.
New York system invests $20.9M in oncology, imaging
Rochester (N.Y.) Regional Health has broken ground on an $8.9 million oncology expansion and a $12 million outpatient imaging center …
You've seen all articles for #oncology.
Check back
soon
for new stories.